PCSK9 and HMG-CoA Reductase Inhibitor Reduce Breast Cancer Risk: Mendelian Randomization Evidence of Metabolic Mediation
收藏科学数据银行2025-05-12 更新2026-04-23 收录
下载链接：
https://www.scidb.cn/detail?dataSetId=9e0f3b79374b478780278153c10c1038
下载链接
链接失效反馈官方服务：
资源简介：
This attachment includes three supplementary tables, which present detailed data from the Mendelian randomization analysis. Refer to the main text for specific methods.Table S1 : Significant SNPs for PCSK9 and HMG-CoA reductase;Table S2 : Effect of PCSK9/HMG CoA reductase inhibitor on CHD;Table S3 : Effect of PCSK9/HMG CoA reductase inhibitor on circulating metabolites and breast cancer.
提供机构：
Renmin Hospital of Wuhan University; LI Qingqing
创建时间：
2025-05-12
